Long-Term Guselkumab Persistence in Plaque Psoriasis
Study shows strong long-term guselkumab persistence in plaque psoriasis, unaffected by BMI or severity, while prior biologic—especially IL-17—use increases discontinuation risk.
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.